Hepatitis C antivirals' most common adverse effect is anemia

04/29/2013 | MedPage Today (free registration)

An analysis of data from more than 1,400 patients in the U.S. found that anemia is the most reported side effect of two direct-acting antiviral drugs used to treat patients with the hepatitis C virus. Researchers found that more than 50% of the patients who took boceprevir or telaprevir experienced anemia. The findings were presented at a liver disease research meeting in Europe.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA